Highlights from the 2022 Seniors Housing Databook

Since the Inflation Reduction Act (IRA) was passed in 2022, significant discussion has been devoted to its potential consequences for the development of new drugs. This report examines whether the IRA has had immediate impacts on drug development in the first half of 2023 through analysis of the companies’ R&D investments and M&A and licensing activities.

Since 2019, ATI Advisory and the Long-Term Quality Alliance, with support from The SCAN Foundation, have led national efforts to advance person-centered, non-medical supplemental benefits in Medicare Advantage.

Beneficiaries who are Black or Latino/a are more likely than white beneficiaries to report difficulty with activities of daily living (ADLs) and other conditions that can negatively impact their health. Understanding the experiences of individuals reporting difficulty with ADLs across race and ethnicity can help policymakers develop strategies to address inequities. This databook, supported by the Robert Wood Johnson Foundation, conveys research findings on the racial and ethnic disparities among this population across social determinants of health, natural community supports, and health care experiences.